Accès à distance ? S'identifier sur le proxy UCLouvain
Lack of efficacy with 3 oral dose levels of TMI-005 (Apratastat), in subjects with active rheumatoid arthritis on a background of methotrexate-A phase 2 double-blind, placebo-controlled, parallel, randomized study
Primary tabs
| Document type | Communication à un colloque (Conference Paper) – Abstract, Présentation orale avec comité de sélection |
|---|---|
| Publication date | 2006 |
| Language | Anglais |
| Conference | "Annual European Congress of Rheumatology (EULAR 2006)", Amsterdam (Netherlands) (Jun 21-24, 2006) |
| Journal information | "Annals of the Rheumatic Diseases" - Vol. 65, p. 339-339 (2006) |
| Peer reviewed | yes |
| issn | 0003-4967 |
| e-issn | 1468-2060 |
| Publisher | B M J Publishing Group (London) |
| Affiliations |
UCL
- Cliniques universitaires Saint-Luc UCL - MD/MINT - Département de médecine interne |
| Links |
| Bibliographic reference | Fleischman, R. ; Durez, Patrick ; Genovese, M. ; Keystone, E. M. ; Pavelka, L. ; et. al. Lack of efficacy with 3 oral dose levels of TMI-005 (Apratastat), in subjects with active rheumatoid arthritis on a background of methotrexate-A phase 2 double-blind, placebo-controlled, parallel, randomized study.Annual European Congress of Rheumatology (EULAR 2006) (Amsterdam (Netherlands), Jun 21-24, 2006). In: Annals of the Rheumatic Diseases, Vol. 65, p. 339-339 (2006) |
|---|---|
| Permanent URL | http://hdl.handle.net/2078.1/59841 |